Literature DB >> 17295770

Evaluation of hernia repair operation in Child-Turcotte-Pugh class C cirrhosis and refractory ascites.

Joo Kyung Park1, Sang Hyub Lee, Won Jae Yoon, Jun Kyu Lee, Su Cheol Park, Bum Joon Park, Yong Jin Jung, Byeong Gwan Kim, Jung-Hwan Yoon, Chung Yong Kim, Jongwon Ha, Kyu Joo Park, Yoon Jun Kim.   

Abstract

BACKGROUND AND AIM: Abdominal wall hernia is a common feature of decompensated liver cirrhosis and frequently causes life-threatening complications or severe pain. However, there have been no data reported on postoperative mortality, hepatic functional deterioration and recurrence rate according to Child-Turcotte-Pugh (CTP) class and to the presence of refractory ascites.
METHODS: The study population comprised 53 liver cirrhosis patients who underwent hernia repair operation. Comparisons were made of 30-day mortality among the different CTP classes, and between those with or without refractory ascites. Liver function was also analyzed just before the operation, in the immediate postoperative period, and in the remote postoperative period.
RESULTS: Seventeen patients were in CTP class A, 27 patients in class B, and 9 patients in class C. The median follow-up duration was 24 months. There was single 30-day postoperative mortality in class C, and no CTP class deterioration after 30 days of operation. There was no mortality or recurrences in 17 patients with medically refractory ascites. The difference in 30-day mortality according to CTP class and the presence of refractory ascites did not show statistical significance (P = 0.17 and 0.97, respectively).
CONCLUSION: Hernia operation could be done safely in CTP class A and B with low rate of recurrences, and there was no definitive increase in the operative risk in class C. In addition, refractory ascites did not increase operative risk and recurrence rate. Therefore, surgical repair might be recommended even in patients with refractory ascites and poor hepatic function to prevent life-threatening complications or severe pain.

Entities:  

Mesh:

Year:  2007        PMID: 17295770     DOI: 10.1111/j.1440-1746.2006.04458.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

1.  Perioperative risk factors in patients with liver disease undergoing non-hepatic surgery.

Authors:  Chandra Kant Pandey; Sunaina Tejpal Karna; Vijay Kant Pandey; Manish Tandon; Amit Singhal; Vivek Mangla
Journal:  World J Gastrointest Surg       Date:  2012-12-27

2.  Inguinal hernia repair in patients with cirrhosis is not associated with increased risk of complications and recurrence.

Authors:  Heung-Kwon Oh; Hansuk Kim; Seungbum Ryoo; Eun Kyung Choe; Kyu Joo Park
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

Review 3.  Umbilical hernia in patients with liver cirrhosis: A surgical challenge.

Authors:  Julio C U Coelho; Christiano M P Claus; Antonio C L Campos; Marco A R Costa; Caroline Blum
Journal:  World J Gastrointest Surg       Date:  2016-07-27

4.  "Tension-free" herniorrhaphy for groin hernias in patients with cirrhosis: report of four cases.

Authors:  Mitsuhiro Inagaki; Junichi Goto; Taishi Okayama; Tatsuya Suzuki; Shinichi Kasai
Journal:  Surg Today       Date:  2009-05-27       Impact factor: 2.549

5.  Abdominal wall hernia in cirrhotic patients: emergency surgery results in higher morbidity and mortality.

Authors:  Wellington Andraus; Rafael Soares Pinheiro; Quirino Lai; Luciana B P Haddad; Lucas S Nacif; Luiz Augusto C D'Albuquerque; Jan Lerut
Journal:  BMC Surg       Date:  2015-05-21       Impact factor: 2.102

6.  Deceased donor liver transplantation performed one week after small bowel resection for complicated umbilical hernia: a case report.

Authors:  Hyung Jun Kwon; Jae Min Chun; Sang Geol Kim; Hyung-Kee Kim; Seung Huh; Yun-Jin Hwang
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2014-08-31

7.  The abdominal wall hernia in cirrhotic patients: a historical challenge.

Authors:  Giuseppe Salamone; Leo Licari; Giovanni Guercio; Sofia Campanella; Nicolò Falco; Gregorio Scerrino; Sebastiano Bonventre; Girolamo Geraci; Gianfranco Cocorullo; Gaspare Gulotta
Journal:  World J Emerg Surg       Date:  2018-07-28       Impact factor: 5.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.